Emmessar Biotech & Nutrition Ltd — Board Meeting, 07-08-2025: Board Meeting

The Company has announced a board meeting to consider and approve the financial results for the quarter and half-year. This meeting is crucial as it will finalize key financial performance metrics. Additionally, the trading window for designated persons and their immediate relatives will be closed, in line with the Company's Code of Conduct for prevention of insider trading. This ensures fair disclosure and prevents misuse of unpublished price sensitive information before the results are made public, a standard practice for corporate governance.